Translational Research

• ‘Real world data’ of genomic sequencing for personalised therapy
• Correlation between an automated functional assay that predicts targeted agent (TA) sensitivity and the tumor response of the sorafenib treatment e...
• Potential prognostic markers for recurrence and survival in triple-negative breast cancer
• miR-4317, a promising player tuning the anti-tumor armamentarium against breast cancer
• TRIB3: A new transcriptional target gene of rapalogs, modulating their effects on splicing
• Identification of resistance mechanisms for EGFR-targeted therapy in head and neck squamous cell carcinoma: Combining whole-exome sequencing and tu...
• Association BRCA mutation status between BMN 673 (talazoparib), an oral PARP inhibitor, in triple-negative breast cancer
• Differences in expression profiling and biomarkers between histological colorectal carcinoma[s] subsets from the serrated pathway
• Emerging role of FAT1 gene in the regulation of oncogenic miRNA 221/222- 3p in glioma
• Role of ATDC gene as a biomarker of doxorubicin response in triple-negative breast cancer
• Gli promotes tumor progression and metastasis through regulating EMT in non–small-cell lung cancer
• Role of miR-449 family on doxorubicin-based chemotherapy response in triple-negative breast cancer
• Synthetic lethal effects of BMN 673 loaded solid lipid nanoparticles on triple-negative breast cancer
• Targeting p63 upregulation may prevent the development of MAPK inhibitor resistance in melanoma
• The reduction of the expression of B-catenin and c-Myc is related to a better outcome in patients with AML
• Leukotriene B4 receptors as a therapeutic target for triple-negative breast cancer
• The clinical impact of miRNA34a and P53 gene expression in colon cancer
• Comparing clonality between components of combined hepatocellular carcinoma and cholangiocarcinoma by targeted sequencing
• The role of topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracycline-based chemotherapy in locally advanced b...
• Does the long noncoding RNA HULC act as a sponge or as a downstream target for miR-186 in hepatocellular carcinoma?
• Mir-506-3p synergistically represses breast cancer progression through altering cell cycle regulators
• Prognostic value of immune gene’s expression in head and neck squamous cell carcinoma patients
• Next-generation sequencing reveals high intra-individual molecular concordance between primary head and neck tumors and matched local or distant re...
• Decreasing telomerase activity of adenocarcinoma cancer cell line (AGS) is associated with different concentrations of sodium selenite and cadmium...

• « Previous
• 1
• 2
• ...
• 123
• Next »